Driving Impaired

17 registered clinical trials studyying Driving Impaired — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Validation of Alcohol Level Identification Using DRIVESC NCT07282405	University of Wisconsin, Madison	N/A
Recruiting	Validating a Novel Driving Simulation-based MWT Against the Standard MWT in an OSA-cohort Challenged by CPAP-w NCT06872593	Stefan Lakämper	N/A
Not Yet Recruiting	Effectiveness of AV-stimulation in Immersive VR to Improve Visual Perception and Driving Performance NCT05703360	University Health Network, Toronto	N/A
Unknown	Cannabis Consumption and Driving Impairment Assessment on a Closed Course NCT06059677	Bayliss J. Camp, PhD	Phase 2
Enrolling By Invitation	Evaluation of an Interactive Mobile Phone-Based Brief Intervention to Reduce Substance-Impaired Driving NCT05537116	Western Kentucky University	N/A
Withdrawn	Effects of Cannabis/Alcohol on Driving Performance and Field Sobriety Tests NCT05273658	University of California, San Diego	Phase 1 / Phase 2
Unknown	Fitness to Drive Among Stroke Patients NCT06111989	National Institute for Medical Rehabilitation, Hungary	—
Completed	Dose-response of Cannabis and Driving NCT03656029	Centre for Addiction and Mental Health	Phase 2
Completed	Reducing Cell Phone Use While Driving Among High Risk UBI Auto Policy Holders NCT04587609	University of Pennsylvania	N/A
Completed	Effect of Postprandial Hyperinsulinaemic Hypoglycaemia on Driving Performance. NCT04330196	Lia Bally	N/A
Completed	Using Advanced Driver Assistance Systems (ADAS) as an Intervention Strategy for Drivers With Parkinson's Disea NCT03195608	Western University, Canada	N/A
Completed	Driving Performance After Deep Sedation for Outpatient Endoscopy NCT04948385	University of Liege	Phase 4
Unknown	Neural Correlates of Driving and Cannabis NCT03581058	Unity Health Toronto	Phase 1
Completed	Smartphone-paired Breathalyzers and Loss- and Gain-framed Texts for Reducing Drinking and Driving NCT03335735	University of Pennsylvania	N/A
Completed	Driving Simulation to Assess Non-Sedative Effects of Tolperisone NCT03353922	Neurana Pharmaceuticals, Inc.	Phase 1
Completed	Validation of Mesopic and Photopic Contrast Vision Tests With Respect to Nighttime Driving Ability NCT03169855	Aalen University	—
Completed	Driving Evaluation and Fitness for Persons With Cognitive Impairments NCT04648735	National Cheng Kung University	N/A